Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.

PURPOSE: To investigate the clinical value of measuring human glandular kallikrein 2 (hK2) compared with free and total prostate specific antigen (PSA-F and PSA-T) in serum from patients with prostate disease. MATERIALS AND METHODS: Serum from healthy controls, from men with benign prostate hyperpla...

Full description

Bibliographic Details
Main Authors: Becker, C, Piironen, T, Pettersson, K, Björk, T, Wojno, K, Oesterling, J, Lilja, H
Format: Journal article
Language:English
Published: Lippincott Williams and Wilkins 2000